GlassScriptPhysician profile
George Wayne Byram
NPI 1992064026
$13,838.87
in general payments reported to CMS, 2019-2025
30 companies · $1,627 in 2025
The $1,627 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,449 · 2020: $774 · 2021: $2,917 · 2022: $2,149 · 2023: $1,716 · 2024: $1,207 · 2025: $1,627.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,549.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,464.15 | 2019-2025 | Mako, Pangea, Gamma |
| Midsouth Orthopedics INC. | $2,982.25 | 2019-2022 | |
| Arthrex, INC. | $1,481.68 | 2021-2024 | Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems, Arthrex |
| Anika Therapeutics, INC. | $403.54 | 2023 | Ovomotion, X-Twist, Tactoset |
| Exactech, INC. | $181.82 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $143.98 | 2021-2025 | Zilretta |
| Medacta USA, INC. | $115.34 | 2024 | |
| Horizon Therapeutics Plc | $105.36 | 2020-2022 | |
| Smith+Nephew, INC. | $96.89 | 2025 | N/A, Na |
| Vericel Corporation | $87.90 | 2021-2025 | Maci |
| Sanofi-Aventis U.S. LLC | $83.45 | 2019-2020 | |
| Wright Medical Technology, INC. | $79.52 | 2019 | |
| Davol INC. | $76.43 | 2022 | |
| Ethicon US, LLC | $64.30 | 2021-2025 | Dermabond Prineo |
| Bioventus LLC | $58.36 | 2023-2024 | Durolane, Exogen Ultrasound Bone Healing System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $45.83 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Sanara Medtech INC. | $41.17 | 2022-2024 | Celleraterx |
| Innovation Technologies INC | $41.06 | 2024-2025 | Irrisept |
| Dynasplint Systems INC. | $40.81 | 2023 | Dynasplint |
| Nalu Medical, INC. | $39.20 | 2025 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $36.45 | 2019 | |
| Abbott Laboratories | $33.93 | 2019-2025 | Eterna |
| Welch Allyn | $24.97 | 2021 | |
| Ucb, INC. | $20.01 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.78 | 2025 | |
| Heron Therapeutics, INC. | $17.74 | 2021 | |
| Amgen INC. | $15.06 | 2025 | Evenity |
| Ferring Pharmaceuticals INC. | $14.91 | 2021 | |
| Axogen | $13.13 | 2021 | |
| Pacira Therapeutics, INC. | $10.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Byram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.